All stock lists
Chemomab Therapeutics Ltd. (NASDAQ:CMMB)
IL · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.07+0.04 (+3.88%)
Insider Score
––Not scored
CMMB Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CMMB Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 1.12 M | 925.00 K | 881.00 K | 884.00 K | 975.00 K | 994.00 K |
| R&D Expense | 1.16 M | 925.00 K | 1.10 M | 960.00 K | 1.29 M | 2.49 M |
| Operating Expenses | 2.28 M | 1.85 M | 1.99 M | 1.84 M | 2.26 M | 3.49 M |
| Operating Income | -2.28 M | -1.85 M | -1.99 M | -1.84 M | -2.26 M | -3.49 M |
| Pretax Income | -2.20 M | -1.77 M | -1.88 M | -1.74 M | -2.06 M | -3.32 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.20 M | -1.77 M | -1.88 M | -1.74 M | -2.06 M | -3.32 M |
| EPS (Basic) | -0.28 | -0.22 | -0.24 | -0.28 | -0.36 | -0.58 |
| EPS (Diluted) | -0.28 | -0.22 | -0.24 | -0.28 | -0.36 | -0.58 |
| Shares Outstanding | 8.00 M | 7.98 M | 7.82 M | 6.18 M | 5.79 M | 5.70 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.